See also
this year's filing and
all EDGAR filings for this company.
PDF Report 0001452011_2013_Tanke_Biosciences_Corp.pdf
Logs
warning |
No stock price available |
subcommand.plot |
{} |
warning |
Missing logo |
subcommand.report |
{} |
info |
Failed to set obs_EconomicCapitalRatio |
industry.us_generic |
{'reason': "KeyError('0001452011')"} |
Graph
Absolute values for 0001452011, Tanke Biosciences Corp
|
xvar |
xval |
0 |
IntangibleAssets |
1,238,025 |
1 |
AssetsCurrent |
22,367,919 |
2 |
PropertyPlantAndEquipment |
4,813,232 |
3 |
remainder_Assets |
429,984 |
4 |
LiabilitiesLongTerm |
792,567 |
5 |
LiabilitiesCurrent |
12,095,685 |
6 |
remainder_Liabilities |
37,948 |
7 |
GeneralAndAdministrativeExpense |
2,571,671 |
8 |
SellingAndMarketingExpense |
2,679,714 |
9 |
remainder_Expenses |
23,835,004 |
10 |
remainder_Revenues |
28,561,829 |
11 |
remainder_NetIncome |
295,556 |
12 |
remainder_ComprehensiveNetIncome |
126,220 |
|
yvar |
yval |
0 |
Assets |
28,849,160 |
1 |
Liabilities |
12,926,200 |
2 |
Expenses |
29,086,389 |
3 |
Revenues |
28,561,829 |
4 |
StockholdersEquity |
15,922,960 |
5 |
NetIncome |
-229,004 |
6 |
ComprehensiveNetIncome |
-163,370 |
7 |
BaseVar |
81,570,824 |
8 |
EconomicCapitalRatio |
1.02 |
Edgar->Model Mapping
Feature Distribution
Change over Time